A health innovation aimed at improving iron absorption in women has received international recognition, earning prestigious awards in Europe, North America, and Asia. The recognition in 2025 underscores a rising global awareness of the necessity for effective iron supplementation solutions. Developed by the Swedish biotics solutions company Probi, this innovation features the clinically studied probiotic strain, Lactiplantibacillus plantarum 299v (LP299V®), which enhances iron absorption while minimizing gastrointestinal side effects common to traditional iron supplements.
Iron deficiency remains a significant public health issue, affecting over 30% of women of reproductive age worldwide. Instead of merely increasing iron intake, Probi’s patented strain is designed to enhance the body’s ability to absorb iron more effectively. LP299V® promotes iron uptake by preserving iron in an absorbable form and increasing the expression of iron-converting enzymes. This dual action facilitates improved absorption from both dietary sources and supplements.
Global Acclaim for Biotic Innovation
The significance of this innovation was highlighted when Probi received the 2025 NutraIngredients-Asia Award for Innovation in Women’s Health on September 17, 2025, in Bangkok. This accolade adds to Probi’s earlier honors from Europe and North America, marking a notable achievement within a single calendar year.
Martina Pettersson, Global Marketing Director at Probi, emphasized the importance of this recognition, stating, “Recognition across three continents in a single year speaks to the urgent, global nature of this issue and to the promise of science-backed, biotic innovations in addressing it.” Such acclaim reflects the pressing need for well-tolerated iron supplementation solutions, particularly in regions like Asia, where iron deficiency continues to impact millions of women.
Karen Ong, Head of Asia-Pacific at Probi, remarked on the critical role of this innovation in addressing health challenges throughout the continent. She noted, “This reinforces how accessible and well-tolerated solutions can make a meaningful difference.”
Three Decades of Research and Development
The probiotic strain LP299V® has undergone extensive research over more than 30 years. Initially recognized for its digestive health benefits, it is now gaining attention for its unique capability to enhance iron absorption, thereby supporting improved health outcomes for women globally.
As a global biotics solutions company, Probi focuses on researching, manufacturing, and delivering biotics for supplements and functional food. Founded in 1991 in Lund, Sweden, Probi has expanded its reach to over 40 markets worldwide and holds numerous patents internationally. Since 2025, Probi has been a part of Symrise AG, a partnership that enhances both its innovative capabilities and global presence.
The recognition of Probi’s innovative approach to iron deficiency highlights the importance of developing effective health solutions that are based on scientific research and that can significantly improve the quality of life for women facing nutritional challenges.
